Podcasts about HIV

Could Ozempic slow—or even reverse—aging? We take a closer look at the science behind the buzzy headlines.References:Semaglutide Slows Epigenetic Aging in People with HIV-associated lipohypertrophy: Evidence from a Randomized Controlled Trial | medRxiv  [pre-print]Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial - PubMedFind a full transcript here. New to Nutrition Diva? Check out our special Spotify playlist for a collection of the best episodes curated by our team and Monica herself! We've also curated some great playlists on specific episode topics including Staying Strong as We Age, Diabetes, Weight Loss That Lasts and Gut Health! Also, find a playlist of our bone health series, Stronger Bones at Every Age. Have a nutrition question? Send an email to nutrition@quickanddirtytips.com.Follow Nutrition Diva on Facebook and subscribe to the newsletter for more diet and nutrition tips. Find out about Monica's keynotes and other programs at WellnessWorksHere.comNutrition Diva is a part of the Quick and Dirty Tips podcast network. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

5—6—3—4—3—1—7—2In the first episode under our new podcast name (it's now the Science Fictions podcast!), we ask whatever happened to all those games that claimed to tell you your “brain age”—games that turned into a whole scientific literature on brain training. We discuss: the still-unresolved question of whether training one specific cognitive ability makes you generally smarter; seemingly endless contrasting meta-analyses; and the small matter of what brain training might tell us about the nature of intelligence.(If you can repeat the list of numbers from the top in reverse order then you have the brain of a 25-year-old. If you're 25 or younger, then I don't know what to tell you.)We're now an official part of the Works in Progress podcast world. You can find their other podcasts, including Hard Drugs, the one we talked about on today's episode (about the remarkable development of a drug for HIV), at podcast.worksinprogress.co. Show notes* The 2008 PNAS paper that started the craze for working memory training* The under-discussed rebuttal* 2013 meta-analysis concluding there's no evidence for far transfer* 2015 meta-analysis concluding there is no convincing evidence brain training is effective* 2016 meta-analysis saying there is no convincing evidence brain training is NOT effective* Very useful and detailed 2016 review of the evidence and the methodological issues inherent in brain training (including active vs. passive control groups)* 2020 meta-meta-analysis arguing that the active-passive distinction doesn't matter* 2023 review criticising the meta-meta-analysis* And the authors' own 2020 meta-analysis* 2022 meta-analysis of commercial brain training in older peopleCreditsThe Science Fictions podcast is produced by Julian Mayers at Yada Yada Productions. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit sciencefictionspod.substack.com/subscribe

In the Public Interest is excited to continue In That Case, its third annual miniseries examining notable decisions recently issued by the US Supreme Court. In this episode, host Felicia Ellsworth speaks with WilmerHale Partner Andrew Rhys Davies and Senior Attorney for the ACLU's National LGBTQ and HIV projects Josh Block about United States v. Skrmetti. The case considers whether a Tennessee state law banning gender-affirming medical care for transgender youth violates the Constitution's Equal Protection Clause.Davies and Block unpack the legal reasoning behind the Supreme Court's 6–3 ruling, including the international context highlighted in WilmerHale's amicus brief. Block also reflects on the decision's potential impact on future civil rights litigation and its immediate consequences for the transgender community and access to gender-affirming healthcare.

In the U.S., there are about 100,000 monkeys, baboons, and other primates living in captivity to support scientific research. About 5,000 of them are at OHSU’s Oregon National Primate Research Center. That’s where researchers do experiments on monkeys to try to get clear data about things like cannabis use during pregnancy, and to find cures for diseases like HIV. Animal rights activists have argued for decades that the center should be closed. And they’re gaining momentum with support from Oregon’s governor and some lawmakers. In addition, scientists who oppose using animals in research argue that the practice has become obsolete and is hindering, not helping the effort to find cures.    OPB health reporter Amelia Templeton recently visited the Oregon National Primate Research Center and talked to a lot of smart people on all sides of this complex topic. She joins us to share her reporting.    Don’t forget to check out our many podcasts, which can be found on any of your favorite podcast apps: Hush Timber Wars Season 2: Salmon Wars Politics Now Think Out Loud And many more! Check out our full show list here.

A move to fine families with children who are out past curfew is on hold for now at the City-County Council. The Marion County Public Health Department launched a new website where residents can request a free HIV test kit. Indiana food banks report growing concerns as food insecurity reaches its highest level in a decade. The future of sports is being shaped at the inaugural TEDSports event in Indianapolis. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org/news and follow us on social media to get comprehensive analysis and local news daily. Subscribe to WFYI News Now wherever you get your podcasts. WFYI News Now is produced by Zach Bundy and Abriana Herron, with support from News Director Sarah Neal-Estes.

We outside with another episode—breaking down the Cutwater blackout in a can, why folks been saying Denzel's name wrong, a wild UK ruling that bald = sexual harassment, and even talk of an alien mothership pulling up.Also on deck:​Uber going cash only ​McDonald's dropping $5–$8 meals​Young Thug's jail calls leaking to the streets​Fight game heavy: Jake Paul vs Tank Davis, Tyson vs Mayweather, Canelo vs Crawford rumors​Magic Johnson, HIV, and today's athletes​Breaking news on the Charlie Kirk assassination

A Serial Killer in the Suburbs of Paris The first victim was spotted by a passerby on August 13, 2025, as officials fished the body out of the Seine in a suburb of Paris near a known gay cruising spot. Divers searching the area found another body, then another, then another. As investigators search for answers and other possible victims, speculation swirls about the motive for the murders.   The Murder of Ryan Godbey: A Family Seeks Justice Ryan Godbey, a beloved member of Canton's LGBTQ+ community, whose a disappearance and murder shocked the Canton, Ohio area in 2025. The arrest and charging of the ex-boyfriends answered some questions, leaving others wide open.  If you or anyone you know is the subject of violence, please use the resources below.  The Brutal Murder of Jacob Zieben-Hood? On August 1, 2025, 34-year-old Jacob Zieben-Hood was found stabbed to death in the Harlem apartment he shared with his husband, Donald Zieben-Hood. Behind their social media image of happiness was a history of domestic violence, protective orders, and escalating threats. From alleged strangulation in February to a knife threat in June, the abuse intensified. On July 31, Jacob called his father during another violent altercation. Hours later, he was dead. Donald was found with self-inflicted wounds and arrested for violating a protective order. Christopher Hunnisett: Vicar's Murderer Freed to Kill Again When the dismembered body of a Reverend Glazebrook was found, his lodger, Christopher Hunnisett, was arrested and put on trial, and found guilty. Acquitted of the vicar's murder, Hunnisett went on a crusade to kill as many "pedos" as he could. Studying investigative techniques, Hunnisett followed a tip to 57-year-old Peter Bick, whom he assumed was an abuser. Pretending to be a date, Hunnisett went to Bick's flat and murdered him. The details of this case are unusual, but in some ways they align with what I've been exploring in the next episode, which is the origins and legacy of the provocation defense. A State of Emergency. Three trans women of color, three cities, all lost to unsolved murderous violence. In Boston, Rita Hester's 1998 murder inspired the Transgender Day of Remembrance. Decades later, her name lives on with a dedicated green space, but justice was never served. Boston Police Department's Homicide Unit at 617-343-4470. You can also submit information anonymously by calling the Boston Police CrimeStoppers Tip Line at 1-800-494-TIPS (8477) or by texting the word “TIP” to CRIME (27463). In Minneapolis, Ra'Lasia Wright, a beloved mentor, was found shot outside a home in 2024. Her loved ones still seek answers, and her case remains open. If you have information regarding the murder of Ra'Lasia Wright in Minneapolis, you can contact the police through several channels: Minneapolis Police Department tipline:  Email tips to policetips@minneapolismn.gov or leave a voicemail at 612-673-5845. In Detroit, Karmin Wells, cherished in the ballroom scene, was killed during what police call a setup date in 2025. Her killer hasn't been caught. CrimeStoppers (anonymous tips): Call 1-800-222-TIPS (8477) or submit information online at CrimeStoppersMN.org.  Tips leading to an arrest and conviction may be eligible for a reward Detroit Police Dept: 313‑596‑2212 Crime Stoppers: 1‑800‑SPEAK‑UP Their lives and their senseless murders deserve justice. DOMESTIC VIOLENCE INTIMATE PARTNER VIOLENCE National Domestic Violence Hotline Phone: 1-800-799-SAFE (7233) Text: Text "START" to 88788 Live Chat & Information: thehotline.org Services are available 24/7, confidential, and support all individuals regardless of identity or background. If you or someone you know is in danger, call 9-1-1 immediately. Additional Inclusive National and LGBTQ+-Specific Resources The Trevor Project Phone: 866-488-7386 Crisis intervention and suicide prevention for LGBTQ+ youth ages 13–24. LGBT National Hotline Phone: 888-843-4564 Confidential peer support, information, and resources for the LGBTQ+ community. Trans Lifeline Phone: 877-565-8860 Peer support and crisis intervention for trans and non-binary individuals. NYC Anti-Violence Project Phone: 212-714-1141 (24/7) Bilingual support for those affected by violence in the LGBTQ+ and HIV+ communities. loveisrespect (National Teen Dating Abuse Helpline) Phone: 1-866-331-9474, Text “LOVEIS” to 22522, or chat on loveisrespect.org Specifically for youth and young adults, including LGBTQ+. DomesticShelters.org Searchable directory covering shelters and services with LGBTQ+-inclusive filters. International and Specialized Resources Thank you, Mystic Magazine Global Resource Guide https://www.mysticmag.com/psychic-reading/domestic-violence-resource-guide/  

David Roussève is a Guggenheim Fellow, magna cum laude Princeton graduate, and Distinguished Professor of Choreography at UCLA, whose work has travelled across the US, Europe, South America, and Great Britain, including major commissions by BAM's Next Wave Festival and Jacob's Pillow. He's received top honors such as the "Bessie" Award, Creative Capital and Herb Alpert Awards, three Horton Awards, and many NEA Fellowships. In this episode, David Roussève joins us to unveil his first full-length solo piece in over 20 years—Becoming Daddy AF Becoming Daddy AF  intricately weaves personal and cultural narratives—revisiting 600 years of ancestry, a decades-long journey with HIV, and the profound loss of a partner—while interrogating identity, resilience, and the layers of selfhood as a queer African American artist. Roussève's perspective on legacy, mortality, and reimagining virtuosity at 64. Listen now to hear this exciting conversation on David's work as he creates dialogue around the nature of love, and the meaning of existence. Becoming Daddy AF  will be running September 26-27 at Kelly Strayhorn Theater in Pittsburgh and October 17-18 at The Nimoy, UCLA's Center for the Art of Performance in Los Angeles.Visit David's Website HERE to learn more!

HIV has been in retreat around the world. Fewer people are dying of the disease.New infections are decreasing. More HIV positive people have access to life saving medicine.Those trend lines have been moving in the right direction for decades. And US investment is one big reason.The Trump Administration dismantled foreign assistance through USAID, it continued PEPFAR — the President's Emergency Plan For AIDS Relief — but much of the work is either no longer happening or happening at a very reduced capacity.For decades, the United States led global efforts to end HIV/AIDS. That's no longer happening. Where will the trend lines go from here? For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org. Email us at considerthis@npr.org.This episode was produced by Jeffrey Pierre. You also heard reporting in this episode from NPR's Gabrielle Emanuel from Zambia.It was edited by Courtney Dorning and Rebecca Davis.Our executive producer is Sami Yenigun.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Bio D-REK's Angels & Warriors was founded by Derek Canas, a long-term survivor who contracted HIV as a child through a blood transfusion following surgery for a congenital heart defect. Born with transposition of the great arteries, Derek underwent open-heart surgery as an infant and has lived with a pacemaker since he was a child. Now on his fifth device, he continues to navigate life with both HIV and chronic heart disease. Over the years, Derek's personal fight evolved into a broader mission. He became a passionate advocate. Not just for himself, but for others living with HIV whose stories are often left out of public awareness and policy conversations. Angels & Warriors was created to spotlight these realities, with a focus on communities that are routinely underrepresented: heterosexual individuals, serodiscordant couples, and long-term survivors. https://www.angelsandwarriors.org/about    

In this solo episode, Lindsey dives into the world of peptide injections, with a focus on the controversial “Wolverine shot” (BPC-157). She explores what peptides are, why they're trending in gyms, wellness clinics, and med spas, and how they're marketed for muscle gain, fat loss, recovery, and anti-aging.Lindsey discusses the science (and lack thereof), FDA concerns, and potential risks like overdosing, contamination, and unregulated use. She closes by reminding listeners that while peptides are intriguing, true health and longevity still come from foundational practices—quality sleep, nutrition, strength training, and meaningful human connection. Listen in to learn more : 01:03 – Why People Use PeptidesClaimed benefits include lean muscle gain, faster recovery, testosterone support, fat loss, and anti-aging. However, the evidence base is thin.01:18 – BPC-157 and Other PeptidesBPC-157: derived from stomach peptides, believed to speed up tissue healing and reduce inflammation.Tesamorelin: studied for HIV-related fat reduction.Sermorelin: targeted for sleep and recovery.CJC-1295 + Ipamorelin: growth hormone–related stacks are popular among bodybuilders.02:28 – Lack of Scientific EvidenceMost data comes from animal studies or small trials, not significant human clinical research.03:55 – FDA ConcernsThe FDA flagged four peptides in 2022; that number jumped to 26 by the end of 2023, showing rapid regulatory scrutiny.04:42 – Anecdotal Use by Doctors and CEOsSome report success with peptides like BPC-157 for injuries, but even they acknowledge the lack of robust science.05:35 – Risks of Overuse and ContaminationOverdosing risks: especially when combining peptides with testosterone, leading to organ enlargement.Contamination/mislabeling: Many peptides sold are unregulated, increasing health risks.06:15 – Back to Basics for LongevityDespite the hype, proven health strategies remain the same: sleep, exercise, protein, reducing sugar, strength training, and social connection.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-lindsey-elmore-show--5952903/support.

Dr. Sameer Vohra, Director of the Illinois Department of Public Health, discusses the Op-Ed he co-authored in the Chicago Tribune on the progress his state has made in treating HIV; Brandon Kufalk, STI Unit Supervisor for the state of Wisconsin, explains the dramatic increase in Syphilis rates since 2019 and how his state has worked to reduce cases; a new ASTHO brief provides key considerations for STI programs during an emergency response; the next session of ASTHO's Public Health Nursing Learning Lab Series takes place on September 24th; and in recognition of Suicide Prevention Month, ASTHO has resources that can help public health leaders protect the communities they serve.  Chicago Tribune: Ending the HIV epidemic is in sight. We can't stop now. Wisconsin Dept of Health Services: New Data Show Congenital Syphilis Increasing in Wisconsin While Other Sexually Transmitted Infections (STIs) Decrease ASTHO Brief: Prioritizing Cases and Contacts: Considerations for STI Programs During Emergency Response ASTHO Webinar: Public Health Nursing Workforce Learning Lab - A Series ASTHO Web Page: Suicide Prevention Offices and Committees Legal Map  

A 22-year-old Utah man is arrested in the killing of prominent right-wing activist Charlie Kirk earlier this week on a university campus. Authorities say Tyler Robinson's family and friends convinced him to turn himself in.And: CBC News has learned the federal government plans to crack down on people willfully intimidating and obstructing others who are entering places of worship, cultural community centres, and schools.Also: More than a thousand electric school buses are pulled off the road in Quebec. The fear — they might burst into flames.Plus: Pierre Poilievre on Charlie Kirk, COVID-19 rates up, Canada's oldest HIV service agency closes after 42 years, and more.

Sex Talk #1: How to be that sexual super hero that he wants out of you when it doesn't come naturally. We give tips on trying new behaviors, being more vocal and practicing before you hit the bedroom. Plus we're advocating for conversation - it's a two way street! Sex Talk #2: We start the conversation on the potential shame of using dating apps to finding confidence to obtaining a partner for a relationship and sex. Hot Topc: One gay influencer couple explains why they think it's important to live in a small town with their children...we give our thoughts... Hot Topic: Markin Wolf is on OF and is a positive role model on HIV status for his fans... Hot Topic: Sabrina Carpenter and Ricky Martin turn of the heat for the VMA's and show their love for the community! Hot Topic: What's going on with "Cabaret" on Broadway amid Billy Porter leaving the show due to a sickness... Thirst Trap: Who took the best NSFW photo of the week and why... Follow Steve V. on IG: @iam_stevev Follow Teddy Alexis on IG: @teddyalexis Follow Kodi on IG: @mistahmaurice Rate and Review us! Wanna drop a weekly or one time tip to TAGSPODCAST - Show your love for the show and support TAGS! Visit our website: tagspodcast.com Needs some advice for a sex or relationship conundrum? Ask TAGS! DM US ON IG or https://www.talkaboutgaysex.com/contact Follow Of a Certain Age on IG: @ofacertainagepod

Will the second Africa climate summit produce tangible solutions to fight for climate justice?Police abuse is widespread in Kenya a new study finds. Rights groups warn the findings expose systemic failures that have left many Kenyans vulnerable to police harassment and violence.And how did Botswana become a leader in eliminating mother-to-child transmission of HIV?Presenter: Charles Gitonga Producers: Ayuba Iliya in Lagos. Priya Sippy, Stefania Okereke, and Yvette Twagiramariya in London. Senior Producer: Paul Bakibinga Technical Producer: Pat Sissons Editors: Maryam Abdalla, Andre Lombard and Alice Muthengi

From Gary Glitter to Rose West; Prince Harry to Harold Shipman… courtroom artist Priscilla Coleman has sketched them all, over five decades documenting Britain's biggest criminal trials. In UK courts, artists can't sketch inside, so she begins by writing what she sees, combining shorthand notes with a photographic memory technique. Under tight deadlines - and often without even a table - she rushes outside to turn those notes into the courtroom images we recognise from the nightly news. In this broad interview with Olly, Priscilla recalls watching the Wagatha Christie trial; considers what she's learned from such diverse case studies as Ian Huntley and Jeffrey Archer; and explains why she thinks the legal system needs to change… Image credit:  Priscilla Coleman/MB Media  —----------------------- Meanwhile, in the Zeitgeist, Ollie Peart joins Olly at the Concours of Elegance at Hampton Court Palace, surrounded by cars worth millions of pounds, to investigate the trend for younger people getting into classic car restoration. Is it a way of avoiding ULEZ charges? Do the tax breaks justify abandoning newer cars altogether? And, assuming you can't afford a Ferrari or a Bentley, what are the upcoming marques to invest in? The answers may surprise you…  —----------------------- Elsewhere, down the Foxhole, Alix Fox - fresh from discovering a kindred spirit in a bondage-themed hair salon - tackles a listener's anxiety about contracting HIV from a non-consensual encounter.  Twenty-five tests, taken over fifteen years, are telling her she doesn't have HIV… is there any chance they could be wrong? —----------------------- Finally, music this month comes from Ipswich-born rapper Piers James, and his new single 'F.O.E'. —----------------------- NOW…

Jed Brewer is the president and founder of Good Loud Media, a nonprofit organization that uses music and video to drive social impact in underserved communities around the world.   In this episode, Jed describes how Good Loud Media operates by bringing together Grammy-winning musicians, renowned psychologists, and subject matter experts to create targeted media campaigns.   Jed explores the concept of empathy in leadership and violence prevention. He explains how mass violence stems from a "death of empathy" where people demonize their enemies, and how perspective-taking through music can help restore human connection even in conflict zones. Jed shares his approach to networking as a superpower for creating change. He emphasizes that success is always a team effort and encourages leaders to view their network as the foundation of any meaningful impact. Listen to this episode to discover how music can be engineered to solve complex social problems and learn practical strategies for building powerful networks that drive systemic change. You can find episode 476 on YouTube, or wherever you get your podcasts! Watch this Episode on YouTube |   Key Takeaways [02:23] Jed reveals something people can't find about him online, that he grew up playing in rock bands and learned at 14 that "music has the power to bring us together" and can "create a place where people feel welcome when they don't feel welcome in other places." [03:36] Jed explains his journey from being a preacher's kid to prison chaplain and also describes how his passion developed through the fusion between music and technology that led him to study engineering while maintaining his love for music, understanding that "technology is a way to drive that forward." [07:02] Jed explains how he got into prison outreach and outlines his startup experience. He reveals a breakthrough discovery.  [13:07] Jed explains the business case for underserved populations, noting that pharmaceutical companies are "leaving money on the table" because potential customers aren't aware of life-saving products like HIV medications that "could be using these products." [15:47] Jed connects his faith background to his mission, explaining that his personal faith centers on "love your neighbor as yourself" and finding ways to "reduce human suffering." [17:03] Jed explains how he brings high-caliber people together and he describes the Narcan project. Jed identifies the messaging challenge where some people viewed Narcan as "something that drug users would have" he also outlines his collaborative process where he works with subject matter experts. [24:27] Jed describes distribution strategy where they put the song "everywhere" - radio, social media, and in-person community outreach - celebrating most when "people amplify it to their own network." [26:54] Jed explains his international focus where he started building relationships with creatives worldwide for cost-effective production and he reveals their focus on preventing mass violence. Jed describes their Nigerian mental health success where they embedded therapeutic breathing exercises in music. [32:57] Jed explains music's unique power, noting that unlike speeches that tell people what to think, music tells them "what to think and how to feel at the same time" because "people don't have their guards up about music." [35:48] Jed defines empathy through perspective taking, explaining that empathy begins with consciously thinking "what would it be like to be this other person" and seeing enemies as human beings, even those you disagree with. [40:18] Jed emphasizes networking importance, stating "Your network is your net worth" and "I don't think anybody succeeds alone" because success is always team success, so "the question is, who's on your team?" [44:25] Jed describes his leadership transition where Good Loud Media is shifting from him "doing everything" to "setting other people up to be the people that are doing things" as they expand internationally. [47:27] Jed delivers his closing call to action, saying "You have a vision in your head of something that you can do to make the world a better place... Do it. Now is the time... The world needs you." [49:10] And remember...“Where words fail, music speaks.” - Hans Christian Andersen   Quotable Quotes "I learned as a kid that music has the power to bring us together. I learned when I was 14 that music can create a place where people feel welcome when they don't feel welcome in other places." "I have always been a firm believer that networking is just how we all get where we're going. We all do better when we've got the riches of friendship." "Dig your well before you're thirsty." For me, the living out of that faith has to do with love your neighbor as yourself…I think that all of us can agree that whenever possible, lessening the amount of suffering in the world and lessening the amount of suffering that our neighbors and that our loved ones face is the morally right thing for us to pursue." "I have discovered few things that produce as much genuine magic as simply asking... There's a famous phrase, you have not, because you ask not. I have learned to ask pretty boldly for things, and most of the time people say yes." "Your network is your net worth. The people that, you know, are. That is your riches in life." "I don't think anybody succeeds alone... I think that success is always team success." "You're telling them what to think and how to feel at the same time. Music is a guided meditation that has both a cognitive and an emotive aspect happening in parallel."In mass violence, there's a death of empathy." "The only way forward is to see our enemies as human beings. And that really is what empathy is." "I think empathy in many ways begins and ends with perspective taking." "There are different seasons in life and there are different phases, and we pass in and out of them." "You have a vision in your head of something that you can do to make the world a better place. I know you do... Do it. Now is the time. Not next week, not next year. Do it. Get started. It won't get easier. The best time to do it is right now.We need you. Get to work. This is your moment, the sign you've been waiting for. This is that sign. Get started with your thing that's going to make the world a better place."   Resources Mentioned The Leadership Podcast | Sponsored by | Rafti Advisors. LLC | Self-Reliant Leadership. LLC | Jed Brewer Website | Good Loud Media Facebook | Jed Brewer LinkedIn | Good Loud Media Instagram |  

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences. In this episode, Dr Camidge sat down with Ken Culver, MD, the director of Research and Clinical Affairs at ALK Positive Inc.  Drs Camidge and Culver discussed the highlights of Dr Culver's career, which has been shaped by clinical practice, research, industry leadership, and patient advocacy. They noted elements of ALK Positive that set it apart from other patient advocacy groups, including its being entirely created, funded, and led by patients with stage IV lung cancer and their caregivers. Culver explained how he collaborates with patients to expand treatment opportunities, meets with companies and universities worldwide, and helps stakeholders recognize both the unmet needs and financial incentives for developing therapies for ALK-positive lung cancer. Culver detailed his path to the oncology field, which began with an intention to practice as a community pediatrician in Iowa. This led him to pursue residency training in California, where he gained diverse clinical experience, particularly in HIV/AIDS at the height of the epidemic. His early research explored HIV transmission in children born to drug-using mothers, highlighting the immunosuppressive effect of drug abuse even in the absence of HIV. During his fellowship, he contributed to pioneering work in gene therapy. He also participated in research that laid the groundwork for tumor-directed therapies, which later influenced large-scale clinical trials. Eventually, Culver explained that transitioned to industry. At Novartis, he contributed to the development of important drugs and witnessed the transformative launch of imatinib (Gleevec), one of the first targeted cancer therapies. Alongside his professional work, Culver established the Foundation for Peace, a nonprofit providing medical and community support in the Dominican Republic, Haiti, and Kenya. This initiative, which began with a mission trip in 1989, has grown to involve hundreds of volunteers annually, offering both medical care and broader community services. In his current role with ALK Positive, Culver noted that he has leveraged patient-led advocacy to influence industry priorities, resulting in several new clinical trials for ALK-positive patients. His work emphasizes balancing discovery research with near-term clinical opportunities to directly benefit patients with cancer today. He also shared how he prioritizes tools to empower patients, such as clinical trial finders, and stressed the importance of having contingency plans before disease progression. Overall, this conversation highlights a career that reflects a consistent commitment to science, patient care, and global service, guided by both professional and humanitarian values.

O noticiário do dia. Especialistas australianos querem promover o PrEP, tratamento contra a aids (sida) que reduz em 99% a chance de se contrair o HIV, em relações sexuais - mas que não é eficaz contra outras doenças venéreas. Conversamos com brasileiros que fazem o tratamento profilático. A homenagem para Angela Ro Ro, a cantora brasileira morta aos 75 anos esta semana. Seu legado e sua importância na música brasileira. De Portugal, Francisco Sena Santos conta que Cristiano Ronaldo está a caminho dos mil gols na carreira aos 40 anos. O novo relatório da OCDE que aponta: Quatro em 10 portugueses adultos só conseguem compreender textos simples e curtos. As redes sociais têm papel nisso? Vamos discutir.

Bongani Bingwa speaks to Fatima Hassan, human rights lawyer and founder of the Health Justice Initiative, about the SA AIDS Conference currently underway with experts and delegates to confront South Africa’s HIV crisis head-on, examining both the progress made and the challenges that remain. While rising numbers reflect the ongoing spread of the virus, they also highlight the success of antiretroviral treatment in keeping millions alive who might otherwise have lost their lives. 702 Breakfast with Bongani Bingwa is broadcast on 702, a Johannesburg based talk radio station. Bongani makes sense of the news, interviews the key newsmakers of the day, and holds those in power to account on your behalf. The team bring you all you need to know to start your day Thank you for listening to a podcast from 702 Breakfast with Bongani Bingwa Listen live on Primedia+ weekdays from 06:00 and 09:00 (SA Time) to Breakfast with Bongani Bingwa broadcast on 702: https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/36edSLV or find all the catch-up podcasts here https://buff.ly/zEcM35T Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702See omnystudio.com/listener for privacy information.

In episode 56 of Going anti-Viral, Dr Steven Grinspoon joins host Dr Michael Saag to discuss managing cardiovascular health in people with HIV. Dr Grinspoon is a clinician in the Neuroendocrine and Pituitary Tumor Clinical Center and faculty member at the Massachusetts General Hospital, and a Professor of Medicine at Harvard Medical School. He is a clinical researcher who studies hypothalamic control of body weight and fat distribution in obesity and lipodystrophy with a focus on the metabolic and cardiovascular consequences of visceral fat accumulation. Dr Grinspoon provides an overview of cardiovascular disease in people with HIV including a review of the REPRIEVE study that evaluated if statin medication is effective to prevent heart disease among people with HIV. Dr Saag and Dr Grinspoon detail the REPRIEVE study results demonstrating that statins lower baseline low-density lipoprotein (LDL) cholesterol levels and discuss the cardiovascular health benefits of lowering LDL cholesterol levels. They discuss arterial plaque, how it is measured and whether plaque can regress individuals on statins. Finally, Dr Saag and Dr Grinspoon discuss goals for follow-up studies to REPRIEVE and other studies looking into the benefits of statins in other populations.0:00 – Introduction1:28 – Overview of cardiovascular disease in people with HIV 3:23 – Overview of the REPRIEVE study, which evaluated if statin medication is effective to prevent heart disease among people with HIV10:51 – REPRIEVE study results lowering baseline LDL cholesterol                       13:26 – Follow-up studies in people who do not have HIV16:20 – How plaque is measured in the arteries19:40 – Regression of plaque in patients using statins 21:15 – Top goals for follow-up studies to REPRIEVEResources: REPRIEVE Study: https://www.reprievetrial.org/ __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Patrick Mbullo Owuor, PhD, a pioneering anthropologist and public health leader, discusses his community-driven solutions to global health challenges in Kenya and beyond. He shares how local action and research are making an impact on HIV, water insecurity and more.   

In this episode of Conversations with CEI, Dr. Steven Fine unpacks some of the latest developments and research presented at the 2025 International AIDS Society (IAS) Conference on HIV Science, held in Kigali, Rwanda. From innovative treatment strategies to advancements in prevention and global health equity, Dr. Fine highlights the pivotal discussions and groundbreaking studies that are shaping the future of HIV care. Tune in to gain a deeper understanding of the strides being made in the fight against HIV and the collaborative efforts driving progress on a global scale. Related Content:  The International AIDS Society (IAS) https://www.iasociety.org/conferences/ias2025 Official site for the IAS 2025, 13th IAS Conference on HIV Science, held in Kigali, Rwanda, from July 14-17, 2025. https://www.iasociety.org/blog/takeaways-ias-2025 Takaways from the IAS 2025 Conference CEI Clinical Consultation Line 1-866-637-2342 A toll-free service for NYS clinicians offering real-time clinical consultations with specialists on HIV, sexual health, hepatitis C, and drug user health. www.ceitraining.org

Planned Parenthood of Illinois is expanding its HIV prevention services to include a new long-acting medication that requires only two injections a year. The treatment, called Yeztugo, was recently approved by the U.S. Food and Drug Administration and is now available at all 13 Planned Parenthood health centers across the state.

On his very first day at San Francisco General Hospital, Dr. Paul Volberding met his first AIDS patient – a moment that shaped his career and left an indelible mark on the fight against an epidemic. Now, more than 40 years later, Volberding reflects on the creation of Ward 86, the nation's first HIV clinics, and how UCSF's compassionate, community-first approach redefined HIV/AIDS care worldwide. The work of Volberding and UCSF's dedicated clinicians and scientists laid the foundation for advancements that continue to save lives today. [Health and Medicine] [Show ID: 40986]

Aubrey Masango speaks to Professor Fareed Abdullah, Director at SAMRC office for AIDS and TB Research who gives insights into some of the conversations taking place in this year's edition of the SA AIDS Conference. They touch on some of the issues plaguing the department of health and research facilities such as the cutting of funding by the US government. Tags: 702, The Aubrey Masango Show, Aubrey Masango, Medical Matters, SA AIDS Conference, HIV, Research, Funding, Medication, Pepfar, US AID The Aubrey Masango Show is presented by late night radio broadcaster Aubrey Masango. Aubrey hosts in-depth interviews on controversial political issues and chats to experts offering life advice and guidance in areas of psychology, personal finance and more. All Aubrey’s interviews are podcasted for you to catch-up and listen. Thank you for listening to this podcast from The Aubrey Masango Show. Listen live on weekdays between 20:00 and 24:00 (SA Time) to The Aubrey Masango Show broadcast on 702 https://buff.ly/gk3y0Kj and on CapeTalk between 20:00 and 21:00 (SA Time) https://buff.ly/NnFM3Nk Find out more about the show here https://buff.ly/lzyKCv0 and get all the catch-up podcasts https://buff.ly/rT6znsn Subscribe to the 702 and CapeTalk Daily and Weekly Newsletters https://buff.ly/v5mfet Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Planned Parenthood of Illinois is expanding its HIV prevention services to include a new long-acting medication that requires only two injections a year. The treatment, called Yeztugo, was recently approved by the U.S. Food and Drug Administration and is now available at all 13 Planned Parenthood health centers across the state.

Planned Parenthood of Illinois is expanding its HIV prevention services to include a new long-acting medication that requires only two injections a year. The treatment, called Yeztugo, was recently approved by the U.S. Food and Drug Administration and is now available at all 13 Planned Parenthood health centers across the state.

In this episode, we review the high-yield topic ⁠HIV in Pregnancy ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Obstetrics section at ⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

Dr Irene Grant is an Infectious Disease specialist with expertise in infectious complications in the immunocompromised and unusual infections in the immunocompetent. In the 1980's, in the midst of the HIV/AIDS epidemic, she trained at Memorial Sloan-Kettering Cancer Center in New York City, under Dr. Donald Armstrong (former President of the Infectious Disease Society of America) where she acquired training in Microbiology and Hospital Infection Control. Thereafter she spent years in academic medicine as an Assistant Professor of Medicine at Albert Einstein College of Medicine (1988 – 2000) and later Clinical Assistant Professor of Medicine at New York Medical College, involved in teaching, clinical epidemiology, and research, while treating inner city patients in the HIV “epicenter” in the Bronx. Later, in private practice, she applied her experience investigating unusual illnesses to help her patients sick from hazardous indoor exposures. For the past 24 years, she has evaluated and treated hundreds of debilitated patients and families with environmentally proven hazardous microbial exposures, correlating the development of multi-system illness with hazardous exposures, the reliability of diagnostic tests, and efficacy of anti-fungal treatment.

In this week's episode, Rex talks with otolaryngologist Dr. Susan Emmett from UAMS about the dangers of hearing loss and the need for specialized care in rural communities throughout Arkansas, especially for K-12 students. The conversation begins with Susan telling Rex about her journey to become an otolaryngologist and how she worked on Capitol Hill with former Tennessee Senator Bill Frist before attending Duke University's School of Medicine. Susan explains to Rex that she became interested in hearing loss during medical school when she studied abroad in East Africa while doing pediatric HIV research. Susan tells Rex that many of the children she cared for during that time suffered from hearing loss and impacted their ability to study in school. Susan explains that hearing loss is much more common than one might think – stating that it affects approximately 684,000 Arkansans or nearly 1 in 4 people – and most people do not even realize they suffer from it. Susan and Rex discuss several contributing factors specific to Arkansans that play a role in the state's high rate of hearing loss, such as noisy farm equipment and hunting rifles. The economic impacts of hearing loss, Susan tells Rex, stems from children not receiving the proper care and testing as well as the limited number of resources capable of identifying and treating hearing loss early on. She says that statistics indicate that children suffering from hearing loss can lead to behavioral problems, and that such children are three times more likely to repeat a grade and three times less likely to graduate from high school. In effect, long-term issues for those who develop hearing loss includes limited job opportunities, increased risk of unemployment and a higher risk of developing dementia. In this episode, Susan also highlights challenges and barriers associated with hearing-related healthcare in rural Arkansas communities as well as innovative programs that UAMS is developing to mitigate those barriers. She also mentions intitiatives on behalf of the National Institutes of Health to bolster telehealth models, software developments and newer, more portable testing devices for those living in rural communities.  Susan explains that these new resources will allow many more children to receive hearing-related treatment and much faster healthcare delivery. Follow Rex Nelson's Southern Fried Podcast on Apple, Spotify, and YouTube, or visit arkansasonline.com/podcast23 for an exclusive subscription offer available only to podcast listeners.  Chapters (00:00:18) - Southern Fried Podcast(00:01:20) - Arkansas physician and advocate for hearing loss access(00:07:21) - Arkansas Workforce Development Council(00:07:46) - The impact of hearing loss in Arkansas(00:10:06) - The First in the Nation Center for Hearing Health Access(00:12:02) - Arkansas lawmakers talk about hearing care in rural areas(00:16:39) - UAMS Hearing Care Connect: Bringing specialty hearing care to rural Arkansas(00:22:39) - Arkansas Senator Tom Cotton on Hearing Care

First up on the podcast, despite so many advances in treatment, HIV drugs can suppress the virus but can't cure the infection. Where does suppressed HIV hide within the body? Staff Writer Jon Cohen joins host Sarah Crespi to talk about the Last Gift Study, in which people with HIV donate their bodies for rapid autopsy to help find the last reservoirs of the virus.   Next on the show, Christine Elliott, a doctoral candidate in the department of entomology at Purdue University, talks about the Bug Bowl—an annual public outreach event that highlights all the wonders and benefits of insects. We also get to hear the sounds of violins trying to be crickets and learn how music connects people to bugs in ways that posters and public lectures can't.   This week's episode was produced with help from Podigy. About the Science Podcast   Authors: Sarah Crespi; Jon Cohen Learn more about your ad choices. Visit megaphone.fm/adchoices

Artist Joyce McDonald was born in 1951 and raised in Brooklyn's Farragut Houses. But she didn't start pursuing art until the 1990s, after being introduced to sculpture in an art therapy program while recovering from drug addiction. McDonald, who was also diagnosed with HIV in 1985, found that art gave her a way to express herself, and honed her craft with Visual AIDS, which supports artists living with HIV. Her ceramic pieces and archival materials are the subject of a new exhibit at the Bronx Museum, 'Ministry: Reverend Joyce McDonald,' on view through January 11. McDonald discusses her life and art, and why she decided to become a minister at the Church of the Open Door.

The dismantling of USAID has created the most profound crisis in international development in decades, threatening to reverse years of progress in public health globally. In the season five premier of Giving Done Right, Phil Buchanan and Grace Nicolette talk with Mark Suzman, CEO of the Gates Foundation, about what this means and how donors can respond. Suzman also shares candid insights about the Gates Foundation's work, including its evolving strategy and Bill Gates' recent announcement committing to spending down $200+ billion in assets by 2045. He offers advice to donors on making a difference in large-scale, global efforts, shares why "one of the huge comparative advantages of philanthropy is being able to take a little bit of risk," and speaks to the role of AI in programs from math education to innovative HIV prevention. Additional Resources Gates Philanthropy Partners CARE Save the Children UNICEF Global Fund to Fight AIDS, TB and Malaria Friends of the Global Fight The End Fund YouthTruth YouthTruth report, “Making Sense of Learning Math: Insights From the Student Experience” The Gates Foundation's announcement about spending down

Tips on making your bottom climax Is it important for making your bottom climax? What works best for your bottom to climax The importance of compromise of within a relationship Respecting differences within a relationship Having respect and admiration for your partner to have a healthy relationship Listener Response: A listener tells us his juicy first time experience that occurred in 9th grade with a 23 year old who lied about his age.... How was your Summer 2025? The hosts share highlights about their Summer and what stood out... Hot Topic: Doctor accidentally severs man's genitals during a length enhancing procedure in South Korea plus we discuss how men in Korea are generally unhappy with their length and size and men in the UK desire larger equipment... Hot Topic: Dr. Demetris Daskalaski warns about the dangers of Sec. RFK Jr's changes to the HHS and CDC that will affect our LGBTQ community Hot Topic: Javier Munoz and Peppermint are leading the crusade to fight for cuts to HIV funding in Washington Hot Topic: We are all here for Sabrina Carpenter's new video for "Tears" which prominently features Colman Domingo in drag! Hot Topic: Joanna Lumley weighs in on the age old debate on whether straight people can play gay... Advice: What it's like to be into water sports and why you might like it too... Advice: What is the "Ick" factor that Gen Z has embraced and have you ever experienced it with a guy? Follow Steve V. on IG: @iam_stevev Follow Lincoln on IG: @madlincoln Follow The Protein Bakery on IG: @proteinbakery Follow Kodi on IG: @mistahmaurice Rate and Review us! Wanna drop a weekly or one time tip to TAGSPODCAST - Show your love for the show and support TAGS! Visit our website: tagspodcast.com Needs some advice for a sex or relationship conundrum? Ask TAGS! DM US ON IG or https://www.talkaboutgaysex.com/contact Follow Of a Certain Age on IG: @ofacertainagepod

Are your kids protected as they head back to school? Tune in for an inspiring discussion with Dr. Diana Howard and the importance of back to school vaccinations.   Moments with Marianne airs in the Southern California area on KMET1490AM & 98.1 FM, an ABC Talk News Radio Affiliate!  https://www.kmet1490am.comDr. Diana Howard is a board-certified Family Medicine and HIV specialist dedicated to advancing health equity for underserved communities. Originally from Lima, Peru, she earned my medical degree from Universidad Ricardo Palma. After being accepted into the UCLA International Medical Graduate (IMG) Pre-Residency Program in Family Medicine, Dr. Howard completed her residency training at Valley Health Team in Fresno, California, where she cultivated a strong commitment to primary care, HIV medicine, and marginalized populations. www.familydoctor.org  For more show information visit: https://www.mariannepestana.com/

This week, Marianna sits down with John Faragon to talk all about the International AIDS Society Conference, which took place in July 2025. Tune in to find out about what was covered, new HIV drugs entering the playing field, and more. -- Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)--Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

Chorea describes involuntary movements that are random, abrupt, and unpredictable, flowing from one body part to another. The most common cause of genetic chorea in adults is Huntington disease, which requires comprehensive, multidisciplinary care as well as support for care partners, who may themselves be diagnosed with the disease. In this episode, Aaron Berkowitz, MD, PhD FAAN speaks with Kathryn P. L. Moore, MD, MSc, author of the article “Huntington Disease and Chorea” in the Continuum® August 2025 Movement Disorders issue. Dr. Berkowitz is a Continuum® Audio interviewer and a professor of neurology at the University of California San Francisco in the Department of Neurology in San Francisco, California. Dr. Moore is an assistant professor and director of the Parkinson's Disease and Movement Disorders Fellowship in the department of neurology at Duke University in Durham, North Carolina. Additional Resources Read the article: Huntington Disease and Chorea Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @AaronLBerkowitz Guest: @KatiePMooreMD Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Berkowitz: This is Dr Aaron Berkowitz with Continuum Audio, and today I'm interviewing Dr Kathryn Moore about her article on diagnosis and management of Huntington disease and chorea, which appears in the August 2025 Continuum issue on movement disorders. Welcome to the podcast, Dr Moore. Could you please introduce yourself to our audience? Dr Moore: Yeah, thank you so much. I'm so excited to be here. I'm Dr Moore. I'm an assistant professor of neurology at Duke University, where I work as a movement disorder specialist. I run our fellowship there and help with our residency program as well. So, I'm excited to speak with our listeners about chorea today. Dr Berkowitz: Fantastic. And we're excited to talk to you about chorea. So, as a general neurologist myself, I only see chorea pretty rarely compared to other movement disorders like tremor, myoclonus, maybe the occasional tic disorder. And like anything I don't see very often, I always have to look up the differential diagnosis and how to evaluate a patient with chorea. So, I was so glad to read your article. And next time I see a patient with chorea, I know I'll be referring to your article as a great reference to have a framework for how to approach it. I hope our readers will look at all these helpful tables on differential diagnosis based on distribution of chorea in the body, potential etiologies, time course of onset and evolution, associated drug-induced causes, what tests to send. So, I highly recommend our listeners read the article. Keep those tables handy for when a patient comes in with chorea. I'm excited to pick your brain about some of these topics today. First, how do you go about distinguishing chorea from other hyperkinetic movement disorders when you see a patient that you think might have chorea? Dr Moore: One of the wonderful things about being a movement disorder specialist is we spend a lot of time looking at movements and training our brain to make these distinctions. The things that I would be looking out for chorea is involuntary, uncontrolled movements that appear to be brief and flowing from one part of the body to another. So, if you can watch a patient and predict what movements they're going to do, this probably isn't chorea. And it should be flowing from one part of the body to another. So, not staying just in one part of the body or having sustained movements. It can be difficult to distinguish between a tic or dystonia or myoclonus. Those things tend to be more predictable and repetitive than the chorea, which tends to be really random and can look like dancing. Dr Berkowitz: That's very helpful. So, once you've decided the patient has chorea, what's your framework for thinking about the differential diagnosis of the cause of the patient's chorea? Dr Moore: Well, that could be really challenging. The differential for chorea is very broad, and so the two things that I tend to use are age of the patient and acuity of onset. And so, if you're thinking about acute onset of chorea, you're really looking at a structural lesion like a stroke or a systemic issue like infection, hyperglycemia, etc. Where a gradually progressive chorea tends to be genetic in nature. When you're thinking about the difference between a child and an adult, the most common cause of chorea in a child is Sydenham's chorea. And actually, the most common cause of chorea that I tend to see is Parkinson's disease medication. So, if anybody's seen dyskinesia in Parkinson's disease, you've seen chorea. But it's those two things that I'm using, the age of the patient and the acuity. Somewhere in the middle, though---so, if you have subacute onset of chorea---it's important to remember to think about autoimmune conditions or paraneoplastic conditions because these are treatable. Dr Berkowitz: That's very helpful. So, like in any chief concern in neurology, we're using the context like the age and then the time course. And then a number of other helpful points in your article about the distribution of chorea in the body. Any comments you'd like to make about- we have this very helpful table that I thought was very interesting. So, you really get deep into the nuances of chorea and the movement disorder specialist expert level. Are there any aspects of parts of the body affected by chorea or distribution of chorea across the body that help you hone your differential diagnosis? Dr Moore: Certainly. I think where the chorea is located in the body can be helpful, but not as helpful as other conditions where you're localizing a lesion or that sort of thing. Because you can have a systemic cause of chorea that causes a hemichorea; that you can have hyperglycemia causing a hemichorea, or even Sydenham's chorea being a hemichorea. But things that we think about, if the forehead is involved, I would think about Huntington's disease, although this is not pathognomonic. And if it's involving the face or the mouth, you can think about neuroacanthocytosis or, more commonly, tardive dyskinesia. Hemichorea would make me think about some of those systemic issues like hyperglycemia, Sydenham's chorea, those sorts of things, but I would rely more on the historical context and the acuity of presentation than the distribution itself. Dr Berkowitz: Got it. That's very helpful. So those can be helpful features, but not sort of specific for any particular condition. Dr Moore: Exactly. Dr Berkowitz: Yeah, I often see forehead chorea mentioned as sort of specific to Huntington's disease. Since I don't see much Huntington's disease myself, what does forehead chorea look like? What is the forehead doing? How do you recognize that there is chorea of the forehead? It's just sort of hard for me to imagine what it would look like. Dr Moore: It's really tricky. I think seeing the eyebrows go up and down or the brows furrow in an unpredictable way is really what we're looking for. And that can be hard if you're having a conversation. My forehead is certainly animated as we're talking about one of my favorite topics here. One of the tricks that I use with the fellows is to observe the forehead from the side, and there you can see the undulation of the forehead muscles. And that can be helpful as you're looking for these things. I think where it's most helpful to use the forehead is if you're trying to determine if someone with a psychiatric history has tardive dyskinesia or Huntington's disease, because there can be quite a lot of overlap there. And unfortunately, patients can have both conditions. And so, using the forehead movement can be helpful to maybe direct further testing for Huntington's disease. Dr Berkowitz: Oh, wow, that's a very helpful pearl. So, if you see, sort of, diffuse chorea throughout the body and the forehead is involved, to my understanding it may be less specific. But in the context of wondering, is the neuropsychiatric condition and movement disorder related by an underlying cause in the case of seeing orofacial dyskinesias, is the relationship a drug having caused a tardive dyskinesia or is the whole underlying process Huntington's, the absence of forehead might push you a little more towards tardive dyskinesia, presuming there is an appropriate implicated drug and the presence of forehead chorea would really clue you in more to Huntington's. Did I understand that pearl? Dr Moore: That's exactly right, and I'm glad you brought up the point about making sure, if you're considering tardive dyskinesia, that there has been an appropriate drug exposure. Because without that you can't make that diagnosis. Dr Berkowitz: That's a very helpful and interesting pearl, looking at the forehead from the side. That is a movement disorders pearl for sure. Sort of not just looking at the forehead from one angle and trying to figure out what it's doing, but going to look at the patient in profile and trying to sort it out. I love that. Okay. So, based on the differential diagnosis you would have crafted based on whether this is sort of acute, subacute, chronic, the age of the patient, whether it's unilateral, bilateral, which parts of the body. How do you go about the initial evaluation in terms of laboratory testing, imaging, etc.? Dr Moore: Well, certainly in an acute-onset patient, you're going to get a number of labs---and that's listed out for you in the paper---and consider imaging as well, looking for an infarct. One thing our learners will know is that sort of the typical answer to what's the infarct causing hemichorea would be the subthalamic nucleus. But really, those infarcts can be almost anywhere. There are case reports for infarcts in a wide variety of places in the brain leading to hemichorea. So, I think some general blood work and an MRI of the brain is a good place to start. For someone who has a more chronic course of the development of chorea, there are certain labs that I would get---and an MRI, because if you get an MRI and there's heavy metal deposition or other disease, structurally, that indicates a certain condition, that can help you pretty considerably. But otherwise, I'm looking for inflammatory markers, heavy metals, HIV, some general other things that are outlined, to help make sure that I'm not missing something that's treatable before I go down the route of genetic testing. And we may talk about this in a little bit, but if you start out with genetic testing and then you sort of have to back up and do more systemic testing, that can be very disjointed when it comes to good patient care. Dr Berkowitz: That's very helpful. So yeah, if it's acute, obviously this is the most straightforward scenario, acute and unilateral. We're imagining something lesional, as you said, either a stroke or---not sort of sudden, but fast, but not sudden---you might think of another structural lesion. Toxoplasmosis, right, has an affinity for the basal ganglia if you were seeing this in a patient who is immunocompromised. But in a case that, probably as you alluded to, sort of what we would see most commonly in practice, those still relatively rare, sort of subacute to chronic symmetric chorea. There's a long list of tests that are recommended. In your article and in other texts, I've read lupus testing, anti-phospholipid antibodies… but the list is long. I'll refer readers to your article. Out of curiosity as a specialist, how often do you see any of these labs come back revealing any underlying diagnosis in a patient who's otherwise healthy and just has developed chorea and comes to you with that chief concern? I feel like I've sent that mega-workup a few times; I'm obviously a general neurologist, but not nearly as many times as you have been. It's- I can't remember a time where something has come up, maybe an ANA one to forty or something like this that we don't think is relevant. But in your practice, how often do you end up finding a reversible cause in the laboratory testing versus ending up starting to go down the genetic testing route, which we'll talk about in a moment? Dr Moore: It's not common, but it is important that we capture these things. Because for a lot of those laboratory tests, there are treatments that are available, or other health implications if those come back positive. So, the case I think of is a polycythemia vera patient who had diffused subacute onset chorea and was able to be treated, was temporarily managed with medication for her chorea, and as her PV improved, she was able to come off those medications. As I was alluding to before---and I'm sure we'll talk about genetic testing---if you test for HD and it's negative, do you go down the route of additional expensive genetic testing, or do you then circle back and go, oops, I missed this treatable condition? As we talk about genetic testing as well, getting HD testing is a pretty involved process. And so, we want to make sure we are checking all those boxes before we move forward. So, it's not common, but we do catch some treatable conditions, and that's really important not to miss. Dr Berkowitz: That's very interesting. So, you diagnosed that polycythemia vera by blood smear, is that how you make the diagnosis? Dr Moore: Yes. Dr Berkowitz: And is that a once-in-a-career-so-far type of thing, or does that happen time to time? Dr Moore: For me, that's a once-so-far, but I don't doubt that I'll see it again. Dr Berkowitz: Great. And how about lupus and some of these other things we look for in the absence of other systemic features? Have you picked up any of these or heard of colleagues picking up something on laboratory testing? They said, oh, this patient came in for a referral for genetic testing, negative Huntington's disease. And good news, we found polycythemia vera; good news, we found undiagnosed lupus and we reversed it. I'm just curious, epidemiologically, seeing these long lists and not having the subspecialty practice that you do, how often you find a reversible cause like we do for neuropathy all the time, right? Oh, it's diabetes, it's B12---maybe not reversible, but preventing progression---or reversible dementia work up. You get so excited when you find low B12 and you replete the patient's B12, and they get better when they had been concerned they were developing an irreversible condition. How often does one in your subspecialty find a reversible cause on that initial mega-lab screen? Dr Moore: I think it's really uncommon, and maybe the folks that do are caught by someone else that never make it to Huntington's clinic, but I don't tend to see those cases. There are, of course, case reports and well-described in the literature about lupus and movement disorders and things of that nature, but that doesn't come to our clinic on a regular basis for sure. Dr Berkowitz: Got it. That's helpful to hear. Well, we've alluded to genetic testing a number of times now, so let's go ahead and talk about it. A lot of your article focuses on Huntington disease, and I was thinking about---in the course of our medical training in medical school, and then neurology residency, for those of us who don't become movement disorder experts like yourself---we learn a lot about Huntington disease. That's sort of the disease that causes chorea, until we later learned there are a whole number of diseases, not just the reversible causes we've been talking about, but a number of genetic diseases which you expertly reviewing your article. So, what are some of the red flags that suggest to you that a patient with chronically progressive chorea---and whom you're concerned for Huntington's or another genetic cause---what are some things you notice about the history, about the exam, the symptoms, the signs, the syndrome, that suggest to you that, actually, this one looks like it might not turn out to be HD. I think this patient might have something else. And as you have alluded to, how do you approach this? Do you send HD testing, wait for it to come back, and then go forward? Are there genetic panels for certain genetic causes of chorea? Do you skip just a whole exome sequencing, or will you miss some of the trinucleotide repeat conditions? How do you approach this in practice? Dr Moore: I'll try to tackle all that. One thing I will say is that a lot of patients with chorea, regardless of the cause, can look very similar to one another. So, if you're looking at chronic onset chorea, perhaps with some neuropsychiatric features, I'm going to most often think about HD because that's the most common cause. Certainly, as we mentioned before, if there's a lot of tongue protrusion, I would think about the acanthocytic conditions, neurocanthocytosis and McCloud syndrome. But generally in those conditions, we're looking at HD as the most likely cause. Certainly, if there is epilepsy or some other syndromic types of things going on, I may think more broadly. But it's important to know that while HD, as you mentioned, is the cause of chorea, many of our patients will have parkinsonism, tics, dystonia, a whole host of other movement phenomenologies. So, that wouldn't dissuade me from thinking about HD. When we think about the kind of patients that you're describing, upwards of 95% of those people will have Huntington's disease. And the process for genetic testing is fairly involved. The Huntington's Disease Society of America has organized a set of recommendations for providers to go about the process of genetic testing in a safe and supportive way for patients and their families. And so that's referred to in the article because it really is important and was devised by patients and families that are affected by this disease. And so, when we're thinking about genetic testing for HD, if I reveal that you have HD, this potentially affects your children and your parents and your siblings. You can have a lot of implications for the lives and health and finances of your family members. We also know that there is high suicidality in patients with HD, in patients who are at risk for HD; and there's even a higher risk of suicidality in patients who are at risk but test negative for HD. So, we do recommend a supportive environment for these patients and their families. And so, for presymptomatic patients or patients who are at risk and don't have chorea, this involves making sure we have, sort of, our ducks in a row, as it were, when we think about life insurance, and, do you have somebody supportive to be with you through this journey of genetic testing, no matter what the results are? So, oftentimes I'll say to folks, you know, there's this 20-page policy that I encourage you to look at, but there are Huntington's Disease Centers of Excellence across the country that are happy to help you with that process, to make sure that the patients are well supported. This is an individual genetic test because, as you mentioned, it is a CAG repeat disorder. And unfortunately, there is no chorea panel. So, if an HD test comes back negative, what we'll do then is think about what's called the HD phenocopies. As I mentioned before, some of these patients who look like they have HD will have a negative HD test. And so, what do you do then? Well, there's a handful of phenocopies---so, other genetic mutations that cause a very similar presentation. And so, we try to be smart, since there's not a panel, we try to be smart about how we choose which test to do next. So, for instance, there's a condition called DRPLA that is present in an African-American family here in my area, in North Carolina, as well as in Japan. And so, if someone comes from those backgrounds, we may decide that that's the next test that we're going to do. If they are white European descent, we may consider a different genetic test; or if they're sub-Saharan African, we may choose a different one from that. However, even if you do a really thorough job, all those blood tests, all those genetic tests, you will occasionally get patients that you can't find a diagnosis for. And so, it's important to know even when you do a good job, you may still not find the answer. And so, I think trying to do things with this complex of the presentation in a systematic way for yourself so you're not missing something. So, going back to our answer about, how do I look at lupus and polycythemia vera and all of that, to think about it in a systematic way. That when you get to the end and you say, well, I don't have an answer, you know you've tried. Dr Berkowitz: That's very helpful to hear your approach to these challenging scenarios, and also how to approach the potential challenging diagnosis for patients and their families getting this diagnosis, particularly in the presymptomatic phase. And your article touches on this with a lot of nuance and thoughtfulness. So, I encourage our listeners to have a read of that section as well. So, last here, just briefly in our final moments, you discuss in your article the various symptomatic treatments for chorea. We won't have time to go into all the details of all the many treatments you discussed, but just briefly, how do you decide which medication to start in an individual patient with chorea for symptomatic management? What are some of the considerations related to the underlying condition, potential side effect profiles of the particular medications, or any other considerations just broadly, generally, as you think about choosing one of the many medications that can be used to treat chorea? Dr Moore: Certainly. So, there is a group of FDA-approved medications, VMAT2 inhibitors, that we can choose from, or the off-label use of neuroleptics. And so, there's a lot of things that go into that. Some of that is insurance and cost and that sort of thing, and that can play a role. Others are side effects. So, for the VMAT2 inhibitors, they all do have a black box warning from the FDA about suicidality. And so, if a patient does struggle with mental health, has a history of suicidality, psychiatric admissions for that sort of thing, then I would be more cautious about using that medication. All patients are counseled about that, as are their families, to help us give them good support. So, the neuroleptics do not tend to have that side effect and can help with mood as well as the chorea and can be helpful in that way. And some of them, of course, will have beneficial side effects. So, olanzapine may help with appetite, which can be important in this disease. So, the big considerations would be the black box warning and suicidality, as well as, are we trying to just treat chorea or are we treating chorea and neuropsychiatric issues? Dr Berkowitz: Fantastic. Thank you for that overview. And again, for our listeners, there's a lot more detail about all of these medications, how they work, how they're used in different patient populations, their side effects, etc, to be reviewed in your excellent article. Again, today, I've been interviewing Dr Kathryn Moore about her article on diagnosis and management of Huntington's disease in chorea, which appears in the August 2025 Continuum issue on movement disorders. Be sure to check out Continuum Audio episodes from this and other issues. And thank you so much to our listeners for joining today. And thank you again, Dr Moore. Dr Moore: Thanks for having me. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

It's May 1991, and Sassy knows exactly what your mom wants most for Mother's Day: you following her around the house quoting statistics about how bad school sucks in this country! When she tells you to give it a rest, you can learn about Kim Frey, a young woman living with HIV, or why you should consider making friends with boys. (It's not because they have amazing answers to the What He Said question about what they'd do if they were invisible, that's for sure.) Also: hay fever, plants, vitamins, deodorant, and more than you ever wanted to know about breast discharge! You're welcome!!! QUICK LINKS

On episode #88 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 8/19/25 – 8/27/25. Host: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination (CDC: MMWR) Bictegravir, emtricitabine, and tenofovir alafenamide versus ritonavir-boosted protease inhibitor-based antiretroviral therapy in people with HIV and viral suppression on second-line therapy in Haiti: an open-label, randomised, non-inferiority trial (LANCET: HIV) Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial (CID) Bacterial Exposure to suppressive antibiotic therapy in women with recurrent urinary tract infections and severity of infections: a retrospective population-based cohort study (BMJ Open) Effectiveness and safety of antibiotics in kidney transplant recipients with asymptomatic bacteriuria: a systematic review and meta-analysis of randomized controlled trials (OFID) Epidemiological, temporal, and geographic trends of leptospirosis in the United States, 2014–2020 (PLoS Neglected Tropical Diseases) Performance of Tongue Swabs for Tuberculosis Diagnosis in Hospitalized Children Under 5 Years of Age (OFID) Fungal The Last of US Season 2 (YouTube) Towards shorter therapy for candidaemia: defining uncomplicated candidaemia in adults (LANCET: Infectious Diseases) Parasitic Outcomes of Military Blood Donors at Joint Base San Antonio with Reactive Trypanosoma cruzi Antibody Screening (OFID) Cutaneous acanthamoebiasis: Two Cases Highlighting Diverse Histopathologic Findings (Journal of Cutaneous Pathology) Miscellaneous Linezolid-related Optic Nerve Disorders: Insight from a Pharmacovigilance Analysis of the U.S. FDA Adverse Event Reporting System (OFID) Extreme variability in linezolid concentrations in the ICU: A case for routine therapeutic drug monitoring (American Journal of Health-System Pharmacy) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

The germ theory of disease is one of the greatest breakthroughs in human history. But it took more than 2,000 years of false starts and resistance before medicine finally recognized that germs cause disease. In his book Germ Theory, Dr. Robert Gaynes unpacks why this shift was so hard to achieve. In this episode, he and Dart explore what it teaches us about paradigm shifts today: why new ideas face such resistance, how the personalities of innovators influence acceptance, and what happens when a powerful new paradigm leads us to overcorrect.Dr. Robert P. Gaynes is an infectious disease physician and Professor of Medicine at Emory University. He is the author of Germ Theory, a CHOICE Outstanding Academic Title.In this episode, Dart and Robert discuss:- Why it took centuries to accept that germs cause disease- What resistance to handwashing reveals about change- Breakthroughs Robert witnessed in his career- How medicine's history reveals patterns of change- HIV's transformation from fatal to treatable- What happens when new paradigms go too far- How personality shapes whether innovations are accepted- Lessons for anyone driving change at work today- And other topics…Dr. Robert P. Gaynes is an infectious disease physician and Professor of Medicine at Emory University. He chairs Emory's Infection Control and Antimicrobial Stewardship Committees, attends at the Atlanta VA Medical Center, and has written extensively on hospital-acquired infections and antimicrobial use. He is the author of Germ Theory: Medical Pioneers in Infectious Disease, named a CHOICE Outstanding Academic Title.Resources Mentioned:Germ Theory: Medical Pioneers in Infectious Disease by Robert Gaynes: https://www.amazon.com/Germ-Theory-Pioneers-Infectious-Diseases/dp/168367376XGet discounted tickets to the Responsive Conference, featuring past Work for Humans guests Bree Groff and Simone Stolzoff – September 17–18, Oakland, CA. Use code “11fold”: https://www.responsiveconference.com/ticketsRegister to attend the UWEBC Conference, where Dart keynotes the HR track alongside Ethan Mollick and Nancy Giordano – September 30, University of Wisconsin: https://uwebc.wisc.edu/conference/registration/Connect with Robert:LinkedIn: https://www.linkedin.com/in/robert-p-gaynes-49b1541/Work with Dart:Dart is the CEO and co-founder of the work design firm 11fold. Build work that makes employees feel alive, connected to their work, and focused on what's most important to the business. Book a call at 11fold.com.

Send us a textThis episode chronicles the life of Vanessa, who has lived with HIV since birth. She shares her early experiences in the hospital, the challenges of growing up with a chronic illness, and the impact of her mother's health struggles. Vanessa discusses her battle with cancer, the emotional toll it took on her, and her journey towards acceptance and resilience. She reflects on the importance of education about HIV, the stigma she faced, and her experiences with relationships. Ultimately, Vanessa emphasizes the strength she has found in her journey and her commitment to advocacy.The Los Angeles Family AIDS NetworkSupport the showThis podcast is brought to you by the Los Angeles Family AIDS Network

Q-BANK: https://www.patreon.com/highyieldfamilymedicineIntro - (0:35),Normal aging (1:37),Mild cognitive impairment (2:37),Reversible causes of dementia (4:50),Vitamin B12 deficiency (5:09),Hypothyroidism (6:25),Pseudo-dementia (6:52),Normal pressure hydrocephalus (7:42),Neurosyphilis (8:57),HIV-associated dementia (10:05),Delerium (11:04),Alzheimer's disease (12:38),Vascular dementia (17:25),Lewy body dementia (18:58),Frontotemporal dementia (20:38),Huntington's disease (21:55),Creutzfeld-Jakob disease (22:54),Practice questions (24:03)

We are joined for a wet and wild episode with the star of Netflix's MerPeople, professional mermaid Blix Unami (Erik Milligan). Blix tells us what mermaids really represent and takes us on an underwater adventure through their sex life, relationship history, and sexual goals. Blix also gives us all a lesson in how to build authenticity and positivity, discussing everything from achieving success in the face of naysayers to getting diagnosed with HIV and how to dive into thriving instead of merely saying "just keep swimming." TW: Verbal Abuse Love How C*m? -- RATE, REVIEW & SUBSCRIBE  Follow Blix @the.blixunami Follow / DM us at @HowCumPodcast @RemyKassimir Support the podcast/ get extras on Patreon Check out our website for extra info & merch!

Do you want to know what happens to a female body during an orgasm?You will be surprised on how they found out about it. Watch my video to know more and let me know your thoughts in the comments.Today's video is sponsored by AdamandEve.com. Code: RENA . 50% Off 1 Item + Free Shipping in the US & Canada. *some exclusions apply Adam and Eve takes sexual health seriously and donates up to o of their profit to help fight the spread of HIV around the world.Thanks for watching!! Schedule an appointment: https://www.renamalikmd.com/appointments Come back EVERY MONDAY & FRIDAY for a NEW videoChapters:00:00 Intro00:09 Female Orgasms: What Happens to Your Body During it?00:20 This video is sponsored by Adam and Eve00:45 William Masters and Virginia Johnson01:07 3 Phases of Orgasm01:08 Excitement Phase02:10 Plateau Phase03:50 Resolution Phase04:28 If you enjoy this video subscribe to the channel!04:34 Conclusion If you like this video, please SUBSCRIBE and don’t forget to press the bell 🔔, like, comment and share. Stay safe and Love all. 😍Rena Malik, MD is a urologist and pelvic surgeon on youtube to educate people about all things urology including erectile dysfunction, how to increase testosterone, problems with sex, premature ejaculation, urinary leakage, or incontinence, overactive bladder, urinary tract infections, prostate issues and more.Subscribe: DISCLAIMER: This video is purely educational and does not constitute medical advice. The content of this video is my personal opinion and not that of my employer(s). Use of this information is at your own risk. Rena Malik, M.D. will not assume any liability for any direct or indirect losses or damages that may result from the use of the information contained in this video including but not limited to economic loss, injury, illness, or death. https://www.youtube.com/c/RenaMalikMD...Share this video with a friend: https://youtu.be/dPY5EOJ0Jsk Learn more about your ad choices. Visit megaphone.fm/adchoices

This week we're talking to two incredible humans who both share their stories of living with HIV in Out of Shadows which is about immigrants living with HIV in Ireland. Born in Himachal India, Pradesh Bhardwaj has been based in Ireland since 2021 and lived with HIV for 9 years. As an activist and proud member of the PozVibe Tribe, he is passionate about visibility, advocacy, and empowering communities. Pradeep Mahadeshwar (he/they) is a visual artist and LGBTQIA+ activist also from India but now based in Dublin. With a rich background in storytelling, writing, photography, illustrations, and filmmaking, Pradeep's work delves deeply into the complexities of identity, migration, and the lived experiences of Queer People of Colour in Ireland and beyond. He is also the founder of Queer Asian Pride Ireland and the Queer Spectrum Film Festival, Pradeep has created platforms that celebrate diversity while addressing the unique challenges faced by the immigrant LGBTQIA+ community in Ireland. Love,Veda and Robbie.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Poz Vibe Podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ is a⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Veda⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Lady and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Robbie Lawlor⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ production. Big thanks to ⁠our sponsors ⁠⁠⁠⁠⁠⁠Dublin Pride ⁠⁠⁠⁠⁠⁠who make this series possible. We'd also like to thank The Boiler House, Man 2 Man, Gay Health Network and The George for all their help and support.Episodes are produced by Veda and Robbie with production assistance and editing by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Esther O'Moore Donohoe⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Artwork, social media assets and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ merch⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ all created by the fragrant Lavender The Queen.⁠⁠ ⁠⁠⁠⁠

Gregory Scarpa, known as “The Grim Reaper,” was a feared capo in the Colombo crime family and one of the most violent figures in the American Mafia. Rising to prominence in Brooklyn during the 1950s, Scarpa became infamous for his ruthless efficiency as a hitman—credited with dozens, if not hundreds, of murders. He ran rackets involving extortion, loan sharking, gambling, and narcotics, while maintaining a reputation as a stylish and brazen enforcer. His willingness to use extreme violence made him indispensable during the Colombo family's bloody internal wars, where he played a decisive role in eliminating rivals and consolidating power for his faction.Scarpa's criminal empire, however, was shadowed by his double life as a longtime FBI informant. Beginning in the early 1960s, he secretly collaborated with federal agents, reportedly even participating in the search for missing civil rights workers in Mississippi during the “Mississippi Burning” case. His relationship with the Bureau deepened in the 1980s under FBI agent Lindley DeVecchio, a partnership that sparked controversy amid claims the FBI allowed Scarpa to operate with impunity in exchange for intelligence. In 1986, he contracted HIV through a tainted blood transfusion, and by the early 1990s, he was terminally ill. Scarpa pleaded guilty to multiple murders in 1993 and died in prison in 1994 from AIDS-related complications—leaving behind a legacy as both one of the Mafia's deadliest killers and one of the FBI's most compromised informants.to contact  me:bobbycapucci@protonmail.comsource:https://www.theguardian.com/world/2007/oct/31/usa.international

Day 1,281.Today, we discuss reports that the US has offered air and intelligence support to a postwar force in Ukraine, the impact of strikes on Russia's energy infrastructure, and hear the latest twist in the ongoing saga of the destruction of the Nord Stream pipeline back in 2022.Contributors:Francis Dearnley (Executive Editor for Audio). @FrancisDearnley on X.Dominic Nicholls (Associate Editor of Defence). @DomNicholls on X.James Rothwell (Berlin Correspondent). @JamesERothwell on X.Content Referenced:Episode feat. interview with Commander of the Finnish Army, Lt Gen Pasi Välimäki:- Apple: https://shorturl.at/LgRLZ - Spotify: https://open.spotify.com/episode/6udyZnDmeAn6w7pY3yJ7tC - YouTube: https://www.youtube.com/watch?v=ApgMj3GpPCk Francis's Video Dispatch in Moldova:https://www.youtube.com/watch?v=gZC5FvDt-u0 Ukrainian morale suffers as troop favourite Warhammer stops translating novels (The Telegraph):https://www.telegraph.co.uk/world-news/2025/08/25/ukrainian-morale-troop-favourite-warhammer-translations-end/ US offers air and intelligence support to postwar force in Ukraine (Financial Times):https://www.ft.com/content/66ec25a0-4af8-467f-9fbe-cf42de890a7e Desperate for more soldiers, Russia recruits HIV-positive prisoners, civilians (Kyiv Independent):https://kyivindependent.com/to-fill-its-ranks-russia-seeks-hiv-positive-recruits-via-social-media-and-ukraines-occupied-territories/ US and Russian officials discussed energy deals alongside latest Ukraine peace talks (Reuters): https://www.reuters.com/business/energy/us-russian-officials-discussed-energy-deals-alongside-latest-ukraine-peace-talks-2025-08-26/ SIGN UP TO THE NEW ‘UKRAINE: THE LATEST' WEEKLY NEWSLETTER:https://secure.telegraph.co.uk/customer/secure/newsletter/ukraine/ Each week, Dom Nicholls and Francis Dearnley answer your questions, provide recommended reading, and give exclusive analysis and behind-the-scenes insights – plus maps of the frontlines and diagrams of weapons to complement our daily reporting. It's free for everyone, including non-subscribers.Subscribe: telegraph.co.uk/ukrainethelatestEmail: ukrainepod@telegraph.co.uk Hosted on Acast. See acast.com/privacy for more information.

Martin Shkreli became a household name when he jacked up the price of a lifesaving HIV drug 5,000 percent. This quickly earned the former hedge fund manager, investor and pharmaceutical CEO the title of "The most hated man in America." But it's his shady accounting and internet trolling that lands the "Pharma Bro" in hot water. This is the story of Martin Shkreli. (Original television broadcast: 2/26/2018) Want to binge watch your Greed? Full episodes and the latest news at: https://www.cnbc.com/american-greed/

This week on The Monday Edit we're talking: the Hurricane Katrina documentary, Amanda Seales & Jubilee, Texas & California redistricting, HIV segregation in prisons, and the Correct the Map campaign,. Check out the JVN Patreon for exclusive BTS content, extra interviews, and much much more - check it out here: ⁠www.patreon.com/jvn⁠  Follow us on Instagram @gettingbetterwithjvn Jonathan on Instagram @jvn and senior producer Chris @amomentlikechris  New video episodes Getting Better on YouTube every Wednesday.  Senior Producer, Chris McClure Producer, Editor & Engineer is Nathanael McClure Production support from Anne Currie, and Chad Hall Our theme music is also composed by Nathanael McClure. Curious about bringing your brand to life on the show? Email podcastadsales@sonymusic.com. Learn more about your ad choices. Visit podcastchoices.com/adchoices